𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular target-based cancer therapy: tyrosine kinase inhibitors

✍ Scribed by Kenji Tamura; Masahiro Fukuoka

Publisher
Springer
Year
2003
Tongue
English
Weight
187 KB
Volume
8
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Targeted molecular therapy of head and n
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model
✍ Daisuke Sano; David R. Fooshee; Mei Zhao; Genevieve A. Andrews; Mitchell J. Fred πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 2 views

## Abstract ## Background We investigated the effects of vandetanib, an inhibitor of vascular endothelial growth factor receptor 2 (VEGFR‐2) and epidermal growth factor receptor (EGFR), alone and in combination with paclitaxel in an orthotopic mouse model of human head and neck squamous cell carci